androstenedione has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chorley, BN; Corton, JC; George, BJ; Hester, SD; Hughes, MF; Kenyon, EM; MacMillan, DK; McQueen, CA; Pandiri, A; Rooney, JP; Ryan, N; Schmid, JE; Sey, YM; Simmons, JE; Tennant, A; Wood, CE | 1 |
| Gildea, JJ; Wang, J; Yue, W | 1 |
2 other study(ies) available for androstenedione and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
From the Cover: Genomic Effects of Androstenedione and Sex-Specific Liver Cancer Susceptibility in Mice.
Topics: Androstenedione; Animals; Biomarkers, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Liver; Liver Neoplasms, Experimental; Male; Mice; Phenotype; Prednisone; Sex Factors; STAT5 Transcription Factor; Time Factors; Transcriptome | 2017 |
Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; CD24 Antigen; Cell Line; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Estradiol; Estrogen Receptor alpha; Female; Gene Expression; Humans; Hyaluronan Receptors; Letrozole; Neoplastic Stem Cells; Nitriles; RNA, Messenger; Spheroids, Cellular; Triazoles | 2013 |